|
HepC Newsletter
|
Dema-@aol.com
|
Jul 16, 2009 09:18 PDT
|
Can-Fite recruits patients for hepatitis C study
Can-Fite is also recruiting patients for a Phase I/II clinical trial for
CF102 for treating liver cancer.
_http://www.globes.co.il/serveen/globes/DocView.asp?did=1000480599&fid=1725_
(http://www.globes.co.il/serveen/globes/DocView.asp?did=1000480599&fid=1725)
A Study of Telaprevir Combined with Peginterferon Alfa-2a and Ribavirin in
Patients with Well-documented Non-response or Relapse After Previous
Peginterferon Alfa-2a and Ribavirin Treatment: Interim Analysis
_http://www.natap.org/2008/AASLD/AASLD_39.htm_
(http://www.natap.org/2008/AASLD/AASLD_39.htm)
Consequences of Hepatitis C Virus (HCV): Costs of a Baby Boomer Epidemic
of Liver Disease
MAY 2009
_http://www.natap.org/2009/HCV/051809_01.htm_
(http://www.natap.org/2009/HCV/051809_01.htm)
Hepatitis Advocacy Update: Congressional Black Caucus Requests Federal
Funding, for African-Americans The HCV Prevalence Rate is Double Compared To
All Others in the USA; Congressmen Request Funding Support; Pres Obama
Recognizes hepatitis with a Statement
_http://natap.org/2009/HCV/052809_01.htm_
(http://natap.org/2009/HCV/052809_01.htm)
Liver Cancer Rates Triple: Hepatocellular Carcinoma Incidence, Mortality,
and Survival Trends in the United States From 1975 to 2005
_http://natap.org/2009/HCV/060309_01.htm_
(http://natap.org/2009/HCV/060309_01.htm)
HCC Surveillance is Needed in USA - Hepatitis C and Hepatocellular
Carcinoma: Grist for the Mill EDITORIAL
_http://natap.org/2009/HIV/062109_01.htm_
(http://natap.org/2009/HIV/062109_01.htm)
********************
NATAP http://natap.org/
_______________________________________________
_More Hep C Articles..._ (http://natap.org/hcv.htm)
_Association between dietary nutrient composition and the incidence of
cirrhosis or liver cancer in the united states population _
(http://natap.org/2009/HIV/071509_01.htm) - (07/15/09)
_Low-fat Diet Helps Genetically Predisposed Animals Avoid Liver Cancer _
(http://natap.org/2009/HCV/061509_01.htm) - (06/15/09)
_Frequent HCV reinfection and superinfection in a cohort of injecting drug
users in Amsterdam _ (http://natap.org/2009/HCV/071509_01.htm) - (07/15/09)
_Vertex Pharmaceuticals Announces Intention to Sell Its Rights to European
Milestone Payments for Telaprevir _
(http://natap.org/2009/HCV/071209_01.htm) - (07/12/09)
4th Intrntnl Wrkshp Clncl Pharm HCV: _Meeting Report - The 4th
International Workshop on Clinical Pharmacology of Hepatitis Therapy_
(http://natap.org/2009/Pharm/Pharm_01.htm) - written by Jennifer J. Kiser, Pharm.D -
(07/12/09)
4th Intrntnl Wrkshp HCV Resist: _New HCV Drugs, Special Population
(Coinfectio) Access: 4th International Workshop on Hepatitis C, Resistance and
New Compounds 25-26 June 2009, Boston, MA U _
(http://natap.org/2009/HCVresist/HCVresist_02.htm) - (06/30/09) FDA Kim Struble's slides
_"Maintenance Therapy Did Not Reduce Incidence of HCC in the HALT-C
Study"_ (http://natap.org/2009/HIV/062109_02.htm) - (06/21/09)
_Hepatitis C Virus Infection and the Risk of Coronary Disease _
(http://natap.org/2009/HCV/070309_01.htm) - (07/03/09)
_Causes of Liver Cancer in HCV: Hepatitis C virus-induced
hepatocarcinogenesis (HCC)) _ (http://natap.org/2009/HCV/060209_01.htm) - (06/01/09)
EASL Report by Robert Gish, MD, NATAP Reports
EASL: _New HCV Drug Report: "Using a new palette of treatment options to
paint the portrait of cure for patients infected with hepatitis C on our
clinical canvas." _ (http://natap.org/2009/EASL/EASL_90.htm) - written by
Robert Gish MD - (05/28/09)
_EASL 44th Annual Meeting (European Association for the Study of the
Liver)_ (http://natap.org/2009/EASL/EASL.htm)
April 22-26, 2009
Copenhagen, Denmark
4th International Workshop on Hepatitis C
Resistance and New Compounds
25-26 June 2009, Boston, MA USA
_FDA Loosens Up HCV Drug Development - HCV Boston Meeting June 27, 2009 _
(http://natap.org/2009/HCVresist/HCVresist_01.htm) - (06/30/09) FDA's Kim
Struble's slides
**************S T R E T C H your technology dollars with great laptop
deals from Dell!
(http://pr.atwola.com/promoclk/100126575x1223081712x1201714210/aol?redir=http:%2F%2Faltfarm.mediaplex.com%2Fad%2Fck%2F12309%2D81939%2D1629%2
D5)
|
|
 |
|
